Therapeutic Targets of the TNF Superfamily
Overview of attention for book
Table of Contents
-
Altmetric BadgeBook Overview
-
Altmetric BadgeChapter 1 Overview of TNF Superfamily: A Chest Full of Potential Therapeutic Targets
-
Altmetric BadgeChapter 2 Therapeutic Interventions Targeting CD40L (CD154) and CD40: The Opportunities and Challenges
-
Altmetric BadgeChapter 3 Targeting TNF for Treatment of Cancer and Autoimmunity
-
Altmetric BadgeChapter 4 Targeting of BAFF and APRIL for Autoimmunity and Oncology
-
Altmetric BadgeChapter 5 The Role of FasL and Fas in Health and Disease
-
Altmetric BadgeChapter 6 OX40 (CD134) and OX40L
-
Altmetric BadgeChapter 7 Targeting CD70 for Human Therapeutic Use
-
Altmetric BadgeChapter 8 4-1BB as a Therapeutic Target for Human Disease
-
Altmetric BadgeChapter 9 RANK(L) as a Key Target for Controlling Bone Loss
-
Altmetric BadgeChapter 10 Targeting the LIGHT-HVEM Pathway
-
Altmetric BadgeChapter 11 GITR: A Modulator of Immune Response and Inflammation
-
Altmetric BadgeChapter 12 Targeting CD30/CD30L in Oncology and Autoimmune and Inflammatory Diseases
-
Altmetric BadgeChapter 13 Tumor Necrosis Factor Receptor Superfamily Member 21: TNFR-Related Death Receptor-6, DR6
-
Altmetric BadgeChapter 14 TRAIL and Other TRAIL Receptor Agonists as Novel Cancer Therapeutics
-
Altmetric BadgeChapter 15 Therapeutic Potential of VEGI/TL1A in Autoimmunity and Cancer
Attention for Chapter 2:
Therapeutic Interventions Targeting CD40L (CD154) and CD40: The Opportunities and Challenges
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (82nd percentile)
-
High Attention Score compared to outputs of the same age and source (90th percentile)
Citations
- dimensions_citation
- 13 Dimensions
Readers on
- mendeley
- 55 Mendeley